CHU Dijon - SCE Hemato

Dijon 21000

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia, Non-Hodgkins Lymphoma

Studies at this site

• A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma — Completed